Diclofenac Sodium: A Review of its Pharmacological Properties and Therapeutic Use in Rheumatic Diseases and Pain of Varying Origin

Drugs

Volumn 20, Issue 1, 1980, Pages 24-48

  Brogden, R N ^a   Heel, R C ^a   Pakes, G E ^a   Speight, T M ^a   Avery, G S ^a  

^a Australasian Drug Information Services ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIRHEUMATIC AGENT; CLOFEZONE; DICLOFENAC; DIFLUNISAL; FLUFENAMIC ACID; GLIBENCLAMIDE; IBUPROFEN; INDOMETACIN; NAPROXEN; OXYPHENBUTAZONE; PHENYLBUTAZONE; PREDNISOLONE; SALICYLIC ACID; SUDOXICAM; SULFINPYRAZIN; SULINDAC; TOLBUTAMIDE; UNCLASSIFIED DRUG; WARFARIN;

ADVERSE DRUG REACTION; ANKYLOSING SPONDYLITIS; ARTHRITIS; DIGESTIVE SYSTEM; DRUG COMPARISON; DRUG TOLERANCE; GASTROINTESTINAL SYMPTOM; GOUT; HEADACHE; JOINT; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS;

ADULT; ANIMALS; ARTHRITIS, RHEUMATOID; ASPIRIN; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DRUG INTERACTIONS; FEMALE; GASTRIC MUCOSA; GOUT; HUMANS; IBUPROFEN; INDOMETHACIN; MALE; MIDDLE AGED; NAPROXEN; OSTEOARTHRITIS; PAIN; PHENYLACETATES; PLATELET AGGREGATION; RHEUMATIC DISEASES; SPONDYLITIS, ANKYLOSING; ULCER;

EID: 0019214026     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198020010-00002     Document Type: Article

References (123)

1. A long-term study of diclophenac sodium in the treatment of rheumatoid arthritis and osteo-arthrosis
2. A test of 100mg Voltaren suppositories in osteoarthritis
3. Analgesia with diclofenac sodium in anorectal surgery
4. Study on a new anti-inflammatory non-hormonal drug, diclofenac sodium in 50 cases
5. Klinische Prufung von diclofenac na (Voltaren) bei Arthrosen
6. The acute gouty attack: Comparative treatment with two non-steroidal antirheumatic drugs
7. Efecto sintomatico y tolerabilidad del diclofenac sodico en la artritis reumatoide
8. Diflunisal — ein neues, lang wirksames steroidfreies Antirheumatikum. Klinische Prufung gegen Diclofenac
9. Diclofenac sodium (Voltarol) and indomethacin: A multicentre comparative study in rheumatoid arthritis and osteoarthritis
10. Results of testing diclofenac sodium in general practice
11. The long term efficacy and tolerability of Voltaren (diclofenac sodium) and indomethacin in rheumatoid arthritis
12. A study of the anti-inflammatory effect of Voltaren in patients with rheumatoid arthritis
13. Comparison of clofezone and diclofenac in the treatment of out-patients suffering from activated (painful) osteoarthrosis
14. Diclofenac and ibuprofen in rheumatoid arthritis and osteoarthritis
15. A double-blind multicentre comparison of diclofenac sodium and naproxen in osteoarthrosis of the hip
16. Diclofenac sodium (Voltarol): A double-blind comparative study with ibuprofen in patients with rheumatoid arthritis
17. How long should long be? Long-term trials in rheumatic diseases
18. The value and results of long term studies with diclofenac sodium
19. Report on a long term tolerability study of up to 2 years with diclofenac sodium (Voltaren)
20. Comparisons of tolerability findings in international clinical trials
21. A review of spontaneously reported adverse drug reactions with diclofenac sodium
22. Double-blind comparative trial with diclofenac sodium and indomethacin, combining 25mg tablets and 100mg suppositories in the treatment of rheumatoid arthritis
23. Experience with diclofenac sodium in Traumato-Orthopedics
24. Voltaren in traumatology
25. Inhibition of arachidonic acid induced mortality in rabbits with several non-steroidal anti-inflammatory agents
26. Diclofenac (Voltarol) in rheumatoid arthritis: A report of a double-blind trial
27. Diclofenac sodium (Voltaren): Results of a multi-centre comparative trial in adult-onset rheumatoid arthritis
28. Diclofenac sodium (Voltarol): Drug interactions and special studies
29. A double-blind comparison of diclofenac sodium (Voltarol) and placebo in patients with rheumatoid arthritis
30. The treatment of acute gouty arthritis with phenylbutazone and Voltaren
31. Clinical trial of GP-45’840 in orthopedic field
32. Diclofenac sodico e ibuprofen en arthritis reumatoide. Estudio comparative doble ciego
33. Quantitative assay of diclofenac in biological material by gas-liquid chromatography
34. A clinical trial of a new anti-inflammatory/analgesic compound in rheumatoid arthritis —GP 45 840
35. Antiinflamatorio no esteroide (diclofenac sodico) en traumatologia
36. Diclophenac sodium, oxyphenbutazone and placebo in sports injuries of the knee
37. Efficacy and tolerability of Voltaren (diclofenac sodium GP 45,840) in rheumatoid arthritis
38. A clinical trial of the analgesic properties of Voltaren (diclofenac sodium)
39. Inhibition of human platelet aggregation by a dibenzazepine compound (GP 44296) and by N-(2,6-dichlorophenyl)- o-aminophenylacetic acid (GP45840)
40. The pharmacokinetics and metabolism of diclofenac sodium (Voltarol) in animals and man
41. An assessment of the efficacy and tolerability of Voltaren in the treatment of inflammation after extraction of teeth
42. South African multicentre trial with Voltaren in osteo-arthritis of the knee
43. Diclofenac sodium (Voltaren) and naproxen in the treatment of rheumatoid arthritis: A comparative double-blind study
44. Metodo doble ciego, a corto plazo, para evaluar la effcacia del dicofenac sodies en la arthritis reumatoide
45. Factors affecting the pharmacokinetics of diclofenac sodium
46. Diclophenac sodium (Voltaren) in rheumatoid arthritis: A double-blind comparison with indomethacin and placebo
47. Efficacy of GP-45’840 on after-pains. Clinical trial with double-blind method
48. Absorption and excretion of GP-45,840, an analgesic and anti-inflammatory drug in human
49. Neue Aspekte der Entzundungshemmung durch nicht-steroide Antiphlogistika: Wirkung von Voltaren
50. The biological significance of inhibition of prostaglandin synthesis
51. 1 from bovine spleen
52. Effect of antirheumatic drugs on neutral protease from human leucocyte granules
53. Beeinflusst Diclofenac die orale. Antikoagulantientherapie und die Plaettchenaggregation
54. Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase
55. Clinical trial of an anti-inflammatory agent (GP 45,840) in dysmenorrhea
56. A gastroscopic and histological double-blind study of the effects of diclofenac sodium and naproxen on the human gastric mucosa
57. A comparative study between diclofenac sodium and indomethacin in degenerative joint and extra-articular disease
58. An open assessment of the efficacy and tolerability of diclofenac sodium in patients with rheumatic disease and a comparative study of diclofenac sodium (Voltarol) with indomethacin in patients with osteoarthritis and rheumatoid arthritis
59. The pharmacology of diclofenac sodium (Voltarol)
60. Diclofenac sodium in ankylosing spondylitis
61. Double-blind, multicentre, between patient study comparing diclofenac and indomethacin in osteoarthritis treated for 3 months. Clinical and biological evaluation, and statistical analysis of results
62. Diclofenac in arthritis
63. Analgesia postamigdalectomia con diclofenac sodico
64. Diclofenac sodium (Voltaren) and indomethacin in the ambulatory treatment of rheumatoid arthritis: A double blind multicentre study
65. Praxisnahe Beurteiling eines neven Antirheumatikums
66. Pharmacological properties of diclofenac sodium and its metabolites
67. A multicentre trial of Voltaren in the treatment of rheumatoid arthritis
68. A double-blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anticoagulant acenocoumarol (nicoumalone)
69. Zur Wirkungspotenz Neuerer Antiphlogistika
70. Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents
71. A comparative trial of diclofenac sodium and flufenamic acid in adult patients with extra-articular rheumatism
72. In vivo inhibition of prostaglandin synthesis in rabbit kidney by non-steroidal antiinflammatory drugs
73. Clinical evaluation of nonsteroidal analgesic and anti-inflammatory agent GP 45,840 for the pain after tooth extraction
74. Effect of diclofenac and naproxen on gastroduodenal mucosa
75. The effect of topically applied agents on ultraviolet erythema in guinea pigs
76. Diclofenac and thrombocyte aggregation
77. The comparative gastric ulcerogenic activities of non-steroid anti-inflammatory drugs
78. Thrombosis prevention by coagulation and platelet aggregation inhibitors in hyperlipemic rats
79. Wirksamkeit und Vertraeglichkeit von ‘Voltaren’ und Indometacin bei Patienten mit ankylosierender Sponylitis
80. Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren
81. Voltaren, an anti-inflammatory agent for use in rheumatology
82. The use of diclofenac sodium, Voltaren, in orthopaedics. Comparison with indomethacin
83. Uber den Einfluss von Diclofenac auf die Glucostaleranz von Diabetikern
84. A double-blind comparison between diclofenac sodium and ibuprofen in osteoarthritis
85. Diclophenac sodium in rheumatoid arthritis and osteoarthritis
86. Der Einfluss von Diclofenac-Natrium auf den Stoffwechsel von Diabetikern unter qualitativer Diat mit und ohne Tolbutamid
87. Once daily dose treatment with a non-steroidal antirheumatic drug (Diclofenac) in osteoarthrosis
88. Results of short term treatment with ‘Voltaren’ as compared with indomethacin and placebo in non-articular rheumatism
89. Efficacy and tolerability of diclofenac sodium vs ibuprofen in osteoarthritis
90. A clinical trial of a new antirheumatic agent: diclofenac sodium
91. Clinical evaluation of a new anti-phlogistic and analgesic agent. Comparative study between sodium-0-(2,6-dichloroanilino) phenylacetate (GP 45840) and indomethacin by double-blind method
92. Multi-centre trial of Voltaren (GP-45’840) on rheumatoid arthritis by double-blind technique
93. A comparison of the short-term effects of ibuprofen and diclofenac in spondylosis
94. Diclofenac (Voltaren) for the treatment of osteo-arthosis: A double-blind comparison with naproxen
95. Voltaren in the treatment of rheumatoid arthritis
96. Diclofenac-Na (Voltaren) in the treatment of osteoarthrosis of the spine: A long term (6 months) comparative trial versus indomethacin
97. Voltaren (diclofenac-sodium) in arthrosis
98. Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II Quantitative determination of the unchanged drug and principal phenolic metabolites in urine and bile
99. Pharmacokinetics of diclofenac sodium (Voltaren) and metabolites in patients with impaired renal function
100. Biotransformation of diclofenac sodium in animals and in man. I. Isolation and identification of principal metabolites
101. Asthmatic attacks induced in aspirin-sensitive patients by diclofenac and naproxen
102. Anti-inflammatory effects of GP 45,840
103. Therapeutic results of Voltaren tablets, an analgesic antiinflammatory agent, in pain following tonsillectomy
104. Clinical experience and results of clinical trials with Voltaren in rheumatic diseases
105. Inhibition of prostaglandin synthetase by tolmetin (Tolectin, McN-2559), a new non-steroidal antiinflammatory agent
106. A short-term between patient comparison of diclofenac sodium and acetylsalicylic acid in osteoarthritis of the knee and hip
107. Diclofenac in rheumatoid disease
108. Effects of GP-45,840 on subchronic experimental inflammations
109. Effects of GP 45/840 on acute experimental inflammations
110. Clinical trial of GP-45-840 — a new analgesic anti-inflammatory agent
111. Gastrointestinale Blutansschiedung unter der Einnahme von Feprazon, Naproxen, Diclofenac
112. A comparative short-term trial with Voltaren (diclofenac sodium) and naproxen in soft tissue rheumatism
113. Vergleichende Multicenter-Prüfung von Diclofenac Na und Ketoprofen bei Weichteilrheumatismus
114. Treatment of osteoarthritis with a new non-steroidal antirheumatic drug. Voltaren
115. Binding of diclofenac-Na (Voltaren) to serum proteins of different species and interactions with other drugs in protein binding
116. Clinical efficacy of GP-45,840 on lumbago and spondylosis deformans
117. Pharmacokinetic studies on diclofenac sodium in young and old volunteers
118. The pharmacokinetics of diclofenac sodium following intravenous and oral administration
119. Effects of N-(2,6-dichlorophenyl)- o-amino-phenyl-acetic acid (GP 45,840) upon platelets, blood coagulation, and fibrinolytic activity
120. The significance of inhibition of prostaglandin synthesis in the selection of non-steroidal antiinflammatory agents